Pacific Biosciences of California, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $414.0M
Liabilities Breakdown FY2020
Total Liabilities: $78.5M
Asset Breakdown
Total Assets: $414.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $81.6M | 19.7% |
| Accounts Receivable | $16.8M | 4.1% |
| Inventory | $14.2M | 3.4% |
| Property, Plant & Equipment | $24.9M | 6.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $276.4M | 66.8% |
Liabilities Breakdown
Total Liabilities: $78.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.6M | 4.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $74.9M | 95.4% |